Fugita Oscar E H, Chan David Y, Roberts William W, Kavoussi Louis R, Jarrett Thomas W
James Buchanan Brady Urological Institute, Johns Hopkins Medical Institute, Baltimore, Maryland 21287, USA.
Urology. 2004 Feb;63(2):247-52; discussion 252. doi: 10.1016/j.urology.2003.09.077.
To review our technique and experience with laparoscopic radical nephrectomy (LRN) in the obese patient population. Obesity has been considered a potential risk factor for poor outcomes in a variety of surgical procedures and has been considered a relative contraindication to laparoscopy. Since 1996, with increased experience and technical modifications, obesity has not been considered a contraindication for laparoscopy at our institution.
Retrospective data were obtained for all patients who underwent LRN from January 1997 to December 2000. A body mass index (Quetelet's index) greater than 30 was used to define obese patients. Technical modifications included slightly greater insufflation pressures and a lateral shift in trocar sites. The obese laparoscopic group was compared with the nonobese laparoscopic group.
Of 101 patients who underwent LRN, 69 were not obese and 32 were obese. No statistically significant differences were observed in any of the analyzed operative data between the nonobese laparoscopic group and obese laparoscopic group, including a mean operative time of 220 and 242 minutes, respectively. Other factors assessed were the time to ambulation, length of hospital stay, conversion rate to an open procedure, and complication rate, which also demonstrated no statistically significant difference. Only one conversion to an open procedure was required in both the obese and the nonobese laparoscopic groups.
With minor technical modifications, LRN can be safely performed in obese patients. Proper trocar site selection and greater insufflation pressures were critical for success. The differences in the intraoperative and postoperative course of LRN in obese and nonobese patients were not statistically significant. Obesity should not be considered a contraindication to laparoscopic nephrectomy.
回顾我们在肥胖患者群体中进行腹腔镜根治性肾切除术(LRN)的技术及经验。肥胖被认为是多种外科手术预后不良的潜在风险因素,且一直被视为腹腔镜手术的相对禁忌证。自1996年以来,随着经验的增加和技术改进,在我们机构肥胖已不再被视为腹腔镜手术的禁忌证。
获取1997年1月至2000年12月期间所有接受LRN患者的回顾性数据。体重指数(奎特莱指数)大于30用于定义肥胖患者。技术改进包括稍高的气腹压力和套管针穿刺部位的侧移。将肥胖腹腔镜组与非肥胖腹腔镜组进行比较。
在101例行LRN的患者中,69例不肥胖,32例肥胖。非肥胖腹腔镜组与肥胖腹腔镜组之间在任何分析的手术数据中均未观察到统计学显著差异,包括平均手术时间分别为220分钟和242分钟。评估的其他因素包括下床活动时间、住院时间、转为开放手术的比例和并发症发生率,这些也均未显示出统计学显著差异。肥胖和非肥胖腹腔镜组均仅需1例转为开放手术。
通过微小的技术改进,LRN可在肥胖患者中安全进行。正确选择套管针穿刺部位和稍高的气腹压力对成功至关重要。肥胖和非肥胖患者LRN术中及术后过程的差异无统计学意义。肥胖不应被视为腹腔镜肾切除术的禁忌证。